1. Home
  2. PESI vs CABA Comparison

PESI vs CABA Comparison

Compare PESI & CABA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Perma-Fix Environmental Services Inc.

PESI

Perma-Fix Environmental Services Inc.

HOLD

Current Price

$14.35

Market Cap

243.9M

Sector

Industrials

ML Signal

HOLD

Logo Cabaletta Bio Inc.

CABA

Cabaletta Bio Inc.

HOLD

Current Price

$2.31

Market Cap

212.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PESI
CABA
Founded
1990
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Environmental Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
243.9M
212.7M
IPO Year
1992
2019

Fundamental Metrics

Financial Performance
Metric
PESI
CABA
Price
$14.35
$2.31
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$14.57
AVG Volume (30 Days)
129.4K
4.2M
Earning Date
03-12-2026
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$60,661,000.00
N/A
Revenue This Year
$9.91
N/A
Revenue Next Year
$62.48
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.25
$0.99
52 Week High
$16.50
$3.67

Technical Indicators

Market Signals
Indicator
PESI
CABA
Relative Strength Index (RSI) 48.69 44.42
Support Level $14.55 $2.42
Resistance Level $16.05 $2.61
Average True Range (ATR) 0.88 0.25
MACD -0.05 -0.03
Stochastic Oscillator 30.32 20.38

Price Performance

Historical Comparison
PESI
CABA

About PESI Perma-Fix Environmental Services Inc.

Perma-Fix Environmental Services Inc is a provider of both nuclear services and the management of nuclear and mixed waste. The company operates through two segments: The treatment segment offers nuclear, low-level radioactive, Mixed, hazardous and non-hazardous waste treatment, processing and disposal services, and the Services segment which generates the majority of the revenue, provides on-site waste management services to commercial and government customers, technology-based services, construction, logistics, and transportation services among others.

About CABA Cabaletta Bio Inc.

Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies and exploring their potential to provide a deep and durable, perhaps curative, treatment for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes Chimeric AutoAntibody Receptor, or CAART cells, that are designed to selectively bind and eliminate only specific B cells that produce disease-causing autoantibodies, or pathogenic B cells, while sparing normal B cells. Its CABA platform encompasses two strategies: CARTA (chimeric antigen receptor T cells for autoimmunity) and CAART (chimeric autoantibody T cells) that have the potential to be applied across a broad range of autoimmune diseases.

Share on Social Networks: